Tombot has raised $6.0M in total across 1 funding round.
Tombot's investors include Bread and Butter Ventures, Jumpstart Foundry.
Tombot is a healthcare robotics company that develops realistic robotic emotional support animals, primarily the puppy "Jennie," designed for seniors with dementia, mild cognitive impairment, and others facing mental health challenges who cannot care for live pets.[1][2][5] Jennie provides companionship benefits like stress reduction and loneliness combat through sensors responding to touch, voice, and movement, with an optional caregiver app for customization and interaction tracking; it targets individuals in homes, assisted living, and memory care via B2C and B2B2C models.[2][3][4] Tombot addresses non-pharmacological mental health solutions in an underserved market, boasting over 16,000-2,500 pre-orders/waitlist customers (figures vary by source), $6.1M Series A funding in 2025 for engineering and regulatory prep, and projections to ship 200,000+ units by end-2026.[3][4][5]
Tombot was founded in 2017 in Valencia, California, by CEO and co-founder Tom Stevens, inspired by his mother's Alzheimer's diagnosis, which forced rehoming her beloved dog for safety reasons.[1][2][5] Stevens and his team previously built and sold a legal automation startup, bringing operational expertise to robotics.[5] The idea evolved into Jennie, a lifelike 8-10 week-old Labrador puppy prototype handcrafted with Jim Henson's Creature Shop for customer studies, which succeeded but needed redesign for durability, affordability, and reliability; Synapse engineering created Alpha I "Clifford" for production.[2] Early traction includes validated market research confirming demand for realistic robots over toys, leading to thousands of pre-orders and partnerships like hospitals and care facilities.[3]
Tombot rides the wave of aging populations and mental health crises, targeting 300M+ global seniors with dementia unable to own live pets, amid rising demand for non-drug interventions like robot-assisted therapy.[5] Timing aligns with post-pandemic assistive tech growth, robotics advancements in healthcare (e.g., disinfection/therapy bots), and U.S. dementia focus before international/condition expansion.[3][4] Market forces include caregiver shortages, BPSD treatment gaps, and insurance potential, positioning Tombot to influence eldercare by normalizing affordable, realistic companions over toys or pharma.[1][3] Competitors like Ageless Innovation offer similar pets but lack Tombot's FDA/monitoring ambitions and pre-order scale.[1]
Tombot is primed to ship Jennie imminently to its backlog, leveraging $6.1M for team growth, manufacturing, and FDA clearance to capture U.S. dementia market share before global scaling and new models with advanced monitoring.[3][4][5] Trends like AI-driven personalization, remote health tech, and reimbursable devices will accelerate adoption, potentially evolving Tombot into a platform leader for mental health robotics amid expanding eldercare needs. This positions them to transform lives as Tom Stevens envisioned—rehoming prevention through tech companionship.[2][5]
Tombot has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Series A in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2025 | $6.0M Series A | Bread and Butter Ventures, Jumpstart Foundry |
